Objectives: The aim of this study is to define the role and effectiveness for an endoscopic third ventriculostomy (ETV) in patients with seconder normal pressure hydrocephalus(SNPH), idiopathic normal pressure hydrocephalus (INPH) and symptomatic longstanding overt ventriculomegaly (SLOVA). Materials and Methods: 3 patients with SLOVA, 3 patients with INPH and 3 patients with SNPH underwent ETV were studied retrospectively. The patients had a follow-up of 1-6 years. Preoperative CT or/and MRI of the brain was done in all cases.Tap test was done in all cases. Clinical examination finding were classified according to the by Japanese Committee for Scientific Research (JCSS) on intractable Hydrocephalus. Patients were studied to evaluate of the patency of ventriculosthomy and aqueduclus slyvius by a Cine PC MR and CSF_DRİVE T2 Sequence MRI after 1-6 years. Results: Headache, gait disturbance and pollakiuria improved in three patients with SNPH underwent ETV, but dementia didn't improve in one patient. Pollakiuria and headache improved in three patients with INPH underwent ETV but preoperative gait disturbance grade three remained unchanged in one patient. Headache improved in three patients with SLOVA underwent ETV. Preoperative gait disturbance grade 3 remained unchanged in one patient, but improved pollakiuria. We confirmed the patency of a third ventriculostomy and decreasing degrees of CSF flow into the aquaductus sylvius. Conclusions: In properly selected patients with SNPH, SLOVA and INPH who had headache ,slight gait disturbance and pollakiuria , mainly those with a short duration of symptoms, ETV may provide good results.
Introduction
The term normal pressure hydrocephalus (NPH) was coined by Hakim in 1964; [25] later, Adams et al. [1] in 1965 used this term to define a clinical syndrome of progressive mental deterioration, gait disturbance, and urinary incontinence associated with hydrocephalus in the setting of normal cerebrospinal fluid (CSF) pressure. In the cases of idiopathic NPH (INPH), no inciting event is identified. However, secondary NPH (SNPH) may develop after subarachnoid hemorrhage, brain injury, and meningitis which probably interfere with CSF absorption. [27, 41] Symptomatic long-standing overt ventriculomegaly in adults (SLOVA) can present with signs and symptoms associated with NPH. [18, 34, 45] The pathophysiological basis of long-standing overt ventriculomegaly (LOVA) is thought to be decreased intracranial compliance associated with relatively high intracranial pressure (ICP) dynamics. [45] The aqueductal stenosis in LOVA is thought to arise congenitally, leading to the associated feature of macrocephaly and expanded or obliterated sella turcica. [34, 38, 45] It remains uncertain why the hydrocephalic entity manifests in late adulthood. Patients with LOVA can decompensate at any time in their adult life with acute symptoms, which are generally well controlled with endoscopic third ventriculostomy (ETV). [2] Late-onset idiopathic aqueductal stenosis (LIAS) in contrast is thought to be acquired. [15, 44] Differentiating LIAS from LOVA can be attempted based on the absence of macrocephaly and absence of expanded or obliterated sella turcica in LIAS as well as thorough medical history to determine a cause for acquired aqueductal stenosis. [34] It has been reported that LIAS patients can present 10-20 years younger than the patients with INPH. [3, 34, 35] The traditional treatment for communicating hydrocephalus is shunt placement, but
Original Article high failure rates and numerous complications with this therapy have been reported. [27, 39, 47, 48, 55] Endoscopic aqueductoplasty (EAP) is an option of the treatment of obstructive hydrocephalus caused by aqueductal stenosis. [10] ETV has become the preferred method to treat obstructive hydrocephalus because of its minimally invasive nature. [7, 8, 28, 35, 36, 39, 42, 54, 63] However, its utility in the treatment of patients with communicating hydrocephalus has not proven conclusively. Many authors suggest ETV for the treatment of NPH initially. [18, 20, 26, 33, 40, 42, 43] ETV reduces the increased systolic pressure in the brain by venting ventricular CSF through the stroma. [26] Phase-contrast magnetic resonance imaging (PC MRI) flow study (Cine PC MR imaging) and CSF_DRIVE pulse to the T2-weighted 3D TSE sequence MRI (CSF_DRIVE T2 secans MRI) are a reliable technique for detecting the patency of a third ventriculostomy [60] and aqueduct of Sylvius. [22, 61] 
Materials and Methods
Three patients with SLOVA, three patients with INPH, and three patients with SNPH underwent ETV at our institution were studied retrospectively. The patients had a follow-up of 1-6 years. Preoperative computed tomography (CT) or/and MRI of the brain was done in all cases [ Figures 1-3 ]. All patients were assessed with walking and psychometric tests before tap test assessments. Tap test was done in all cases because it is the standard test used in these cases. The tap test was regarded as positive if two or more of three different test items improved after CSF removal. Walking and psychometric tests used to assess patients postoperatively.
ETV was performed with a freehand standard method using a rigid endoscope in all nine patients. Outcome was evaluated according to the data collected at the last follow-up visit. Clinical examination findings on intractable hydrocephalus were classified according to the Japanese Committee for Scientific Research's (JCSR) grading score [ Table 1 ]. The cumulative score of the triad of symptoms was used for determining the severity of the clinical syndrome (total grade: 0-12).
We used a risk ratio (RR) scale tolerated postoperative improvement to the preoperative status: RR = (preoperative − postoperative JCSR score/ preoperative JCSS score × 100).
Clinical outcome was defined as excellent (RR: 75-100 points), good (RR: 50-75 points), satisfactory (RR: 25-50 points), and poor (RR ≤25points). Any patient who died as a result of the ETV procedure or had to Postoperative CT or/and MRI was done in all cases. Six patients were studied to evaluate of the patency of ventriculostomy and aqueduct of Sylvius by a Cine PC MR and CSF_DRİVE T2 sequence MRI after 1-6 years.
Results
The range of positive response to a spinal tap test was 90% in nine patients. There were no major intraoperative complications. No deaths related to surgery or permanent neurological deficits occurred. All patients had no confirmed occlusion of the stroma after 1-6 years. There were no confirmed infections.
The cause of communicating hydrocephalus in the three patients with SNPH was determined to be hypertensive intracerebral hemorrhage (HIH) in two and combined with hypertension and cerebral infarction in one. The patients ranged in age from 51 to 65 years old (mean 60 years old). The actual follow-up ranged from 1 to 5 years. The Japanese Cosmetic Science Society (JCSS) scores of two patients were 2. JCSS score of one patient with dementia was 3 [ Tables 2 and 3 ]. Three patients with SNPH presented gait instability and pollakiuria at the time of surgery; in all of them, gait disorder and pollakiuria resolved completely. Dementia as reported by one patient, but this patient remained stable. Three patients with SLOVA ranged in age from 28 to 32 years old (mean 30.3 years old). Mean head circumference of patients was 61 cm. Follow-up period was 6 years. The causes of decompensation of two patients with SLOVA cases were head injury (HI) (in one patient, this was traumatic intracerebral hemorrhage operated by craniectomy, and in one patient, this was chronic subdural hematoma operated by burr-hole drainage and dysfunction of ventriculoperitoneal [VP] shunting). JCSS scores of two patients were 2. JCSS score of one patient was 4 [ Tables 2 and 3 ]. Among the group of SLOVA (three patients), all patients showed improvement in headache and pollakiuria. Three patients presented gait instability at the time of surgery; in two of them, gait disorder resolved completely while one patient with 4 score remained stable [ Tables 2 and 3 ]. We confirmed the patency of a third ventriculostomy and decreasing degrees of CSF flow into the aqueduct of Sylvius by Cine PC MR imaging and CSF_DRIVE T2 secans MRI 6 years after ETV [ Figures 2, 4-6, and 10-12] .
Discussion
The precise underlying mechanisms of communicating hydrocephalus remain unknown. Communicating hydrocephalus is caused by decreased compliance, increasing the systolic pressure transmission into the brain. [20, 26, 34] The systolic force compresses the brain, including the intracranial capacitance, cerebral veins, and capillaries. If the CSF pressure exceeds the venous pressure, the cerebral ventricles enlarge progressively. Although the ventricular enlargement may normalize the ICP, the systolic pulsations continue to chronically damage the brain parenchyma, which does not absorb them because of its increased elastance. This series of events results in a decrease of cerebral blood flow, insufficient cerebral perfusion pressure, and increased in ICP. The patent aqueduct in communicating hydrocephalus is too narrow to vent the ventricular CSF sufficiently. [23, 24] Rekate explored the sites of obstruction to the flow of CSF that causes hydrocephalus. [49] These sites include not only the aqueduct and outlet foramina of the fourth ventricle but also the basal cisterns blocking the CSF a flow. The obstructive hydrocephalus would be called intraventricular and extraventricular. The intraventricular hydrocephalus includes both obstruction of the aqueduct and occlusion of the outlet foramina of the fourth ventricle. The extraventricular hydrocephalus includes the compression of CSF pathways by mass, i.e., tumors or hematomas. It is common belief that there is some extent of adhesive obstruction in the basal cisterns of communicating hydrocephalus caused by traumatic injury, HIH, and tubercular meningitis. Reasons that revealed symptoms in three patients with SNPH and two patients with LOVA were head injury (HI), HIH, meningitis, and lacunar infarct. No reason has been found in one LOVA case. Both the lumbar infusion test [42, 59, 62] and the tap test [11, 26, 60] can predict a positive outcome of shunt operations in patient with suspected NPH. CSF tap test was done all patients by us. Clinical improvement after the lumbar puncture (which may be sustained for several days or weeks) indicates that the patient is likely to benefit from shunting; however, the tap test is not completely reliable. [26] The range of positive response to a spinal tap test was 90% in nine patients.
The traditional treatment for communicating hydrocephalus is shunt placement, but high failure rates and numerous complications with this therapy have been reported. [27, 39, 47, 50] Torsnes et al. revived 430 articles about outcome of the patients with INPH after shunt treatment. Approximately 40% of the studies were prospective. The overall success rate from surgical treatment varied from 30% to 90%. [59] We observed 66.6% excellent success rate, and 33.3% satisfactory success rate in nine patients underwent ETV.
ETV is a safe and minimally invasive procedure that has been used since 1993 in the treatment of many types of hydrocephalus. The most common indications include primary aqueductal stenosis and triventricular hydrocephalus resulting from external aqueductal compression [6] [7] [8] 13, 28, 31, 35, 36, 39, 42, 52, 54, 63, 64] and tetraventricular obstructive hydrocephalus [18, 32] although this technique is also useful in NPH. [18, 20, 26, 33, 40, 42, 43] ETV results in a slight decrease of the CSF pressure within the ventricular system, with a consequent increase of the cerebral blood flow and cerebral perfusion pressure and abolition of transependymal resorption. [26] The rapid transmission of the pressure wave through the ventriculostomy toward the basal cisterns could restore the normal CSF dynamics. Cerebral aqueductoplasty is an effective and successful treatment for membranous and/or short-segment stenosis of the sylvian aqueduct. EAP candidates must be selected very carefully, but longer follow-up periods are necessary to evaluate long-term aqueductal patency after aqueductoplasty. [10] The reclosure rate of aqueducts after EAP is higher than the reclosure rate of the ventriculostomy after ETV. [57] Aqueductoplasty with stenting is the procedure of choice for the treatment of isolated fourth ventricle. [51] Membranous and tumor-related aqueductal stenosis should be treated by ETV. [14, 38] Patients with LOVA can decompensate at any time in their adult life with acute symptoms. The cause of decompensation in two patients with SLOVA was long-segment aqueductal stenosis occurred after HI. There is no factor that decompensated in one patient with SLOVA. We performed ETV in three patients with SLOVA. [2, 56] However, Kiefer et al. proposed that gravitational shunts may be considered an equivalent alternative to the third ventriculostomy for the treatment of SLOVA. [34] After ETV, we have observed excellent results in these patients. One patient has Grade 3 gait disturbance, Grade 1 urinary incontinence, and headache. After ETV, gait disturbance grade did not change, but headache and urinary urgency improved in 3 months.
We observed 66.6% excellent success rate and 33.3% satisfactory success rate in patient with SLOVA underwent ETV. Some authors reported 66%-89% rate of success in patients with SLOVA. [2, 56] Since ventricular size may change little after fenestration, [35] postoperative follow-up may rely primarily on resolution of clinical symptoms. The use of such a change as an arbiter of success in this procedure is questionable as clinically successful cases can have no change in ventricular size. [8] All patients had a satisfactory clinical outcome after ETV, but we did not observed a decrease of the ventricular size. Some authors considered that clinical outcome is the most important guide to success or failure as reduction in ventricular size is by no means guaranteed. [8] The others reported that a decrease of the ventricular size detected soon after ETV is associated with a satisfactory clinical outcome. [8, 54] This response continues during the 1 st few months after surgery. The reduction is more prominent in acute forms of hydrocephalus. [50, 54] Since ventricular size may change little after fenestration, [35] postoperative follow-up may rely primarily on resolution of clinical symptoms. When a patient presents with residual or recurrent symptoms after a third ventriculostomy, it is important to differentiate fenestration closure from malabsorption since the former may be explored for refenestration while the later requires shunting.
PC MRI flow study (Cine PC MR imaging) and CSF_DRIVE pulse to the T2-weighted 3D TSE sequence MRI (CSF_DRIVE T2 secans MRI) are a reliable technique for detecting the patency of a third ventriculostomy [60] and aqueduct of Sylvius. [22, 61] The overall success rate after ETV was 66% in patients with SNPH, SLOVA, and İNPH. Some authors reported 21%-90% success rate for NPH [20, 26, 34] and 80% success rate for obstructive hydrocephalus cases after ETV. [19] We believed that gait disturbance is just a reflection of local alterations in corresponding cortex and blood supply. [20, 24] The range of clinical history and preoperative clinical score seems to significantly influence postoperative results; patients with a more recent onset of clinical symptoms and less severe preoperative neurological involvement fare significantly better. However, mental state reflects the preserved grade of whole-brain compliance and the extent of massive parenchymal damage. [20, 24] Complications occur in 7%-38% of the patients who undergo ETV. [20, 27, 29, 53, 59] Twenty-two percent of the patients require additional surgery, and 6% experienced permanent neurological deficit or death after shunting for INPH. [27, 59] These mainly include hemorrhages related to the surgical procedure at the level of the choroid plexus, ventricular walls, ventriculostomy, or interpeduncular cistern, whereas intraparenchymal or subdural bleeding, transient neurological deficits, CSF leak, and infections are exceptional. [20] In our series, we observed only one epidural frontal hematoma not requiring surgical evacuation (10%), but we did not observe postoperative subdural hematoma, subdural effusion, CSF leak, and infection. We did not observe to the reclosure of the ventriculostomy in all cases after 5.5 years.
Complication rate of all patients underwent ETV was lower than those treated with VP shunt in all NPH patients. [5, 58] We advise performing ETV in patients with less JCSS score and a clinical evolution of no more than 6 months before diagnosis.
Conclusions
In properly selected patients with SNPH, SLOVA, and INPH who had headache, slight gait disturbance, and pollakiuria, mainly those with a short duration of symptoms, ETV provides good results.
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